{"transactions":[{"id":3506015,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157067,"kind":"organization","name":"Cambridge Innovation Capital (Jersey) Ltd","position":1,"cik":"0001776911","reported_name":"Cambridge Innovation Capital (Jersey) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B2 Preferred Shares","published_at":"2019-05-31T21:12:49.000Z","date":"2019-05-28","kind":"exercise","acquired":false,"shares":229741,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":229741},"source":{"system":"sec-edgar","filing":"0001104659-19-033169","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919033169/a4.xml","form_type":"4"}},{"id":3506014,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157067,"kind":"organization","name":"Cambridge Innovation Capital (Jersey) Ltd","position":1,"cik":"0001776911","reported_name":"Cambridge Innovation Capital (Jersey) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B1 Preferred Shares Warrants","published_at":"2019-05-31T21:12:49.000Z","date":"2019-05-28","kind":"other","acquired":false,"shares":125587,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the  Issuer's initial public offering."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":125587},"source":{"system":"sec-edgar","filing":"0001104659-19-033169","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919033169/a4.xml","form_type":"4"}},{"id":3506013,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157067,"kind":"organization","name":"Cambridge Innovation Capital (Jersey) Ltd","position":1,"cik":"0001776911","reported_name":"Cambridge Innovation Capital (Jersey) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B1 Preferred Shares","published_at":"2019-05-31T21:12:49.000Z","date":"2019-05-28","kind":"exercise","acquired":false,"shares":1081823,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1081823},"source":{"system":"sec-edgar","filing":"0001104659-19-033169","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919033169/a4.xml","form_type":"4"}},{"id":3506012,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157067,"kind":"organization","name":"Cambridge Innovation Capital (Jersey) Ltd","position":1,"cik":"0001776911","reported_name":"Cambridge Innovation Capital (Jersey) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-31T21:12:49.000Z","date":"2019-05-29","kind":"purchase","acquired":true,"shares":314286,"price":14,"value":4400004.0,"ownership":{"direct":true},"balance_after":1751437,"source":{"system":"sec-edgar","filing":"0001104659-19-033169","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919033169/a4.xml","form_type":"4"}},{"id":3506011,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157067,"kind":"organization","name":"Cambridge Innovation Capital (Jersey) Ltd","position":1,"cik":"0001776911","reported_name":"Cambridge Innovation Capital (Jersey) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-31T21:12:49.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":229741,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":1437151,"source":{"system":"sec-edgar","filing":"0001104659-19-033169","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919033169/a4.xml","form_type":"4"}},{"id":3506010,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157067,"kind":"organization","name":"Cambridge Innovation Capital (Jersey) Ltd","position":1,"cik":"0001776911","reported_name":"Cambridge Innovation Capital (Jersey) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-31T21:12:49.000Z","date":"2019-05-28","kind":"other","acquired":true,"shares":125587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":1207410,"source":{"system":"sec-edgar","filing":"0001104659-19-033169","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919033169/a4.xml","form_type":"4"}},{"id":3506009,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":157067,"kind":"organization","name":"Cambridge Innovation Capital (Jersey) Ltd","position":1,"cik":"0001776911","reported_name":"Cambridge Innovation Capital (Jersey) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-31T21:12:49.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":1081823,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":1081823,"source":{"system":"sec-edgar","filing":"0001104659-19-033169","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465919033169/a4.xml","form_type":"4"}}]}